Spreadex Market Update

Europe has hot start on remdisivr, Chinese car news, ignoring global covid-19 spike



Following a muddled, rocky week, Monday got off to a spritely start, as investors turned a blind eye to the bulk of the latest covid-19 headlines, instead cherry picking the most optimistic news items – pretty much a requirement at the moment if you want to see some green.

Firstly, the bad news. The WHO has just reported a record increase in global coronavirus cases, with the USA, Brazil, India and South Africa helping to drive 230,370 new cases in the space of 24 hours.

In the United States specifically Florida finds itself slipping further and further into a truly scary situation, with 15,299 new cases on Sunday – no state has seen a higher one-day figure since covid-19 reached American shores.

And any long-term hopes for ‘herd immunity’ – a buzz phrase at the start of the pandemic, especially in the UK – were dealt a major blow, with tests showing the number of antibodies in people who have recovered from covid-19 fall below immunity levels after a few months.

BUT, Chinese car sales were up 11.61% year-on-year, so phew, crisis averted.

Granted, with a 3rd month of consecutive growth, that bodes well for Thursday’s 2nd quarter GDP reading, which could show the Chinese economy bouncing back by 2.2%, from Q1’s 6.8% contraction.

And it wasn’t just the Chinese automobile industry giving the markets a boost. The latest trial results from Gilead showed further evidence that remdisivr is effective at reducing the risk of death in severely ill coronavirus patients. A shame, then, that the US has secured the world stock of the antiviral drug until the start of October at the earliest...

Regardless of the myriad reasons not to, Europe came out of the gates hot. The FTSE shot up 1.5%, putting 6200 back in its sights, with the DAX crossing 12800 following a 190 point climb, and the CAC passing 5000 on the back of a 1.3% rise.

Currently the Dow Jones is heading for a slighter tamer open, though a 0.7% increase would still lift it above 26250.

SEARCH FOR AN ARTICLE:

Enter a keyword and search for all relevant articles

MARKET ANALYSIS

RECENT POSTS

Financial Trading Blog

Gold Wobbles Ahead of Global PMIs

Read More

Daily Market Update

22.04.26 Wednesday Morning

The S&P 500 closed lower on Tuesday as doubts over the Iran ceasefire weighed on sentiment, while the US dollar...

Read More

Economic Diary

22.04.26

Read More

Financial Trading Blog

FTSE 100 Under Pressure From Oil Ahead of CPI, Sainsbury's Earnings

Read More

Economic Diary

21.04.26

Read More

Weekly Technical Analysis

Weekly Technical Analysis

Read More

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 61% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.